AGIO
- Agios Pharmaceuticals, Inc.
()
Overview
Company Summary
Agios Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the discovery and development of innovative therapies for rare genetic diseases and cancer. The company's main focus is on using its deep understanding of cellular metabolism and the genetic causes of disease to develop targeted medicines that address unmet needs in these therapeutic areas.
Agios is known for its expertise in the field of metabolism, specifically in the area of cellular metabolism, which involves the processes by which cells convert nutrients into energy and essential biomolecules. The company's research and development efforts revolve around identifying and targeting specific metabolic pathways that are instrumental in disease development and progression.
In the area of rare genetic diseases, Agios employs its knowledge of metabolism to develop therapies that can modulate abnormal metabolic processes caused by genetic mutations. These therapies aim to address the underlying cause of the disease and improve patient outcomes.
In the field of oncology, Agios focuses on developing precision medicines that target cancer cells with specific metabolic dependencies. By inhibiting or altering these metabolic pathways, Agios aims to disrupt cancer cell growth and survival, delivering more effective and potentially less toxic treatments for patients with certain types of cancer.
Agios has a pipeline of investigational medicines, some of which have received regulatory approvals and are in advanced stages of development. The company collaborates with various partners, including other pharmaceutical companies, academic institutions, and research organizations, to expand and accelerate its drug discovery and development efforts.
Overall, Agios Pharmaceuticals strives to translate its deep understanding of cellular metabolism and genetic drivers of disease into therapeutic innovations that have the potential to improve the lives of patients with rare genetic diseases and cancer.